Tarsus Pharmaceuticals (TARS) News Today $69.75 +1.33 (+1.94%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$69.05 -0.70 (-1.00%) As of 04:39 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TARS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Why Tarsus Pharmaceuticals (TARS) Is Up 21.6% After Xdemvy’s Uptake and New Trial Announcements—And What's Next3 hours ago | finance.yahoo.comWeiss Ratings Reaffirms "Sell (D-)" Rating for Tarsus Pharmaceuticals (NASDAQ:TARS)4 hours ago | marketbeat.comTarsus Pharmaceuticals (NASDAQ:TARS) Reaches New 52-Week High - What's Next?October 6 at 11:29 AM | marketbeat.comTarsus Pharmaceuticals (NASDAQ:TARS) Trading 9.6% Higher - Time to Buy?October 3, 2025 | marketbeat.comTarsus Pharmaceuticals (NASDAQ:TARS) Sets New 12-Month High - Should You Buy?September 30, 2025 | marketbeat.comTarsus Pharmaceuticals (NASDAQ:TARS) CEO Sells $332,220.00 in StockSeptember 27, 2025 | insidertrades.comBobak Azamian Sells 6,000 Shares of Tarsus Pharmaceuticals (NASDAQ:TARS) StockSeptember 26, 2025 | marketbeat.comTarsus Pharmaceuticals: Considering If The Big Marketing Push Will Pay OffSeptember 26, 2025 | seekingalpha.comTarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Average Recommendation of "Moderate Buy" by AnalystsSeptember 25, 2025 | marketbeat.com5,600 Shares in Tarsus Pharmaceuticals, Inc. $TARS Purchased by Strs OhioSeptember 24, 2025 | marketbeat.comAssenagon Asset Management S.A. Trims Position in Tarsus Pharmaceuticals, Inc. $TARSSeptember 22, 2025 | marketbeat.comWoodline Partners LP Trims Stake in Tarsus Pharmaceuticals, Inc. $TARSSeptember 15, 2025 | marketbeat.comTarsus Pharmaceuticals (NASDAQ:TARS) Stock Price Down 4.1% on Insider SellingSeptember 13, 2025 | marketbeat.comTarsus Pharmaceuticals (NASDAQ:TARS) Director William Phd Link Sells 27,116 SharesSeptember 12, 2025 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Harrow Health (HROW) and IDEAYA Biosciences (IDYA)September 10, 2025 | theglobeandmail.comAdage Capital Partners GP L.L.C. Acquires New Shares in Tarsus Pharmaceuticals, Inc. $TARSSeptember 7, 2025 | marketbeat.comBaird Financial Group Inc. Decreases Stake in Tarsus Pharmaceuticals, Inc. $TARSSeptember 7, 2025 | marketbeat.comCormorant Asset Management LP Sells 100,000 Shares of Tarsus Pharmaceuticals, Inc. $TARSSeptember 6, 2025 | marketbeat.comCutter Capital Management LP Acquires 92,500 Shares of Tarsus Pharmaceuticals, Inc. $TARSSeptember 6, 2025 | marketbeat.comAlly Bridge Group NY LLC Sells 45,212 Shares of Tarsus Pharmaceuticals, Inc. $TARSSeptember 5, 2025 | marketbeat.comTarsus Pharmaceuticals (NASDAQ:TARS) Sets New 12-Month High - Time to Buy?September 4, 2025 | marketbeat.comTarsus Pharmaceuticals, Inc. $TARS Shares Sold by Frazier Life Sciences Management L.P.September 4, 2025 | marketbeat.comNorthern Trust Corp Grows Stake in Tarsus Pharmaceuticals, Inc. $TARSSeptember 3, 2025 | marketbeat.comGhisallo Capital Management LLC Acquires New Stake in Tarsus Pharmaceuticals, Inc. $TARSSeptember 2, 2025 | marketbeat.comTarsus Pharmaceuticals, Inc. $TARS Position Increased by Paradigm Biocapital Advisors LPSeptember 2, 2025 | marketbeat.com5,284 Shares in Tarsus Pharmaceuticals, Inc. $TARS Purchased by FORA Capital LLCSeptember 1, 2025 | marketbeat.comTarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Consensus Recommendation of "Moderate Buy" by AnalystsSeptember 1, 2025 | marketbeat.comDriehaus Capital Management LLC Invests $36.88 Million in Tarsus Pharmaceuticals, Inc. $TARSAugust 31, 2025 | marketbeat.comWellington Management Group LLP Trims Stock Position in Tarsus Pharmaceuticals, Inc. $TARSAugust 31, 2025 | marketbeat.comJump Financial LLC Takes $2.51 Million Position in Tarsus Pharmaceuticals, Inc. $TARSAugust 29, 2025 | marketbeat.comTarsus to Participate in Upcoming Investor ConferencesAugust 27, 2025 | globenewswire.com16,020 Shares in Tarsus Pharmaceuticals, Inc. $TARS Acquired by Quantbot Technologies LPAugust 27, 2025 | marketbeat.com3 Biotech Catalysts Present Major Opportunity (TARS)Three promising biotech names stand out for potentially catalyzing drugs currently on the market or in development; here's why they may rally further.August 25, 2025 | marketbeat.comTarsus Pharmaceuticals, Inc. $TARS Shares Sold by Aberdeen Group plcAugust 24, 2025 | marketbeat.comNuveen LLC Purchases New Shares in Tarsus Pharmaceuticals, Inc. $TARSAugust 24, 2025 | marketbeat.comVanguard Group Inc. Increases Stock Position in Tarsus Pharmaceuticals, Inc. $TARSAugust 24, 2025 | marketbeat.comTarsus Pharmaceuticals, Inc. $TARS Shares Sold by Atika Capital Management LLCAugust 23, 2025 | marketbeat.comRussell Investments Group Ltd. Acquires 132,450 Shares of Tarsus Pharmaceuticals, Inc. $TARSAugust 23, 2025 | marketbeat.comTarsus Pharmaceuticals, Inc. $TARS Shares Sold by Invesco Ltd.August 20, 2025 | marketbeat.comLord Abbett & CO. LLC Acquires 51,714 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)August 16, 2025 | marketbeat.comInsider Selling: Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) CEO Sells 6,000 Shares of StockAugust 15, 2025 | marketbeat.comLyme Disease Is Spiking. This Biotech Nears A Treatment And A Buy Point.August 15, 2025 | msn.comTarsus Pharmaceuticals, Inc. (NASDAQ:TARS) CEO Sells $300,000.00 in StockAugust 14, 2025 | insidertrades.comInformed Momentum Co LLC Decreases Stock Holdings in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)August 14, 2025 | marketbeat.comStocks To Watch: Tarsus Pharmaceuticals Sees RS Rating Jump To 87August 12, 2025 | msn.comBlair William & Co. IL Sells 15,814 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS)August 12, 2025 | marketbeat.comQ3 EPS Forecast for Tarsus Pharmaceuticals Raised by AnalystAugust 11, 2025 | marketbeat.comBrokers Offer Predictions for TARS Q3 EarningsAugust 11, 2025 | marketbeat.comAnalyst Estimates: Here's What Brokers Think Of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) After Its Second-Quarter ReportAugust 9, 2025 | finance.yahoo.comFY2027 Earnings Forecast for TARS Issued By HC WainwrightAugust 9, 2025 | marketbeat.com Get Tarsus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TARS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TARS Media Mentions By Week TARS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TARS News Sentiment▼0.460.63▲Average Medical News Sentiment TARS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TARS Articles This Week▼26▲TARS Articles Average Week Get the Latest News and Ratings for TARS and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Tarsus Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Verona Pharma PLC American Depositary Share News Revolution Medicines News Grifols News Rhythm Pharmaceuticals News Avidity Biosciences News Abivax News Legend Biotech News Cytokinetics News Nuvalent News Axsome Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TARS) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tarsus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tarsus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
